Whilst the focus is on the pharmacutical market is all very positive , to me the most pleasing and new aspect to the report is:
Clinical market progress
In the clinical market, the Company are working with Quest Diagnostics in the United States to get the APAS® instrument into
routine use and connected to their laboratory systems. This will be an important demonstrating the benefits and efficiencies
of the technology, as a precursor to the potential roll out of the technology across the Quest Diagnostics group.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
-0.001(5.56%) |
Mkt cap ! $30.01M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.7¢ | $7.147K | 406.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 666706 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 610640 | 2 |
View Market Depth
| Last trade - 14.23pm 13/06/2025 (20 minute delay) ? |
| CC5 (ASX) Chart |